Institutional Ownership Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL). We have compiled data on the 154 institutions that hold shares in the stock, with a total of 109 Million shares, which have been reported (via 13F filing form) to have a value of $319 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Lindbrook Capital, LLC
|
Nov 01, 2024 Q3 2024 |
5,392
shares
|
$15,906
0.0% of portfolio
|
Q3 2024
Added 116.72%
|
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
5,234
shares
|
$15,440
0.0% of portfolio
|
Q3 2024
Reduced 93.4%
|
|
|
Ever Source Wealth Advisors, LLC
|
Nov 08, 2024 Q3 2024 |
5,000
shares
|
$14,750
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
Frankfurt Am Main, 2M |
Nov 14, 2024 Q3 2024 |
2,300
shares
|
$6,785
0.0% of portfolio
|
Q2 2022
Reduced 61.67%
|
|
|
Global Retirement Partners, LLC
|
Oct 16, 2024 Q3 2024 |
2,000
shares
|
$5,900
0.0% of portfolio
|
Q1 2024
Added 380.77%
|
|
|
Parallel Advisors, LLC
|
Nov 13, 2024 Q3 2024 |
1,998
shares
|
$5,894
0.0% of portfolio
|
Q3 2024
Added 80.81%
|
|
|
Us Bancorp \De\
|
Oct 28, 2024 Q3 2024 |
1,496
shares
|
$4,413
0.0% of portfolio
|
Q3 2024
Reduced 6.27%
|
|
|
Principal Securities, Inc.
Des Moines, IA |
Oct 28, 2024 Q3 2024 |
1,469
shares
|
$4,333
0.0% of portfolio
|
Q3 2024
Added 27.74%
|
|
|
Daiwa Securities Group Inc.
Tokyo, M0 |
Nov 12, 2024 Q3 2024 |
1,151
shares
|
$3,395
0.0% of portfolio
|
Q4 2022
Added 8.58%
|
|
|
Jones Financial Companies Lllp
|
Nov 12, 2024 Q3 2024 |
925
shares
|
$2,728
0.0% of portfolio
|
Q3 2024
Reduced 71.81%
|
|
|
Eagle Bay Advisors LLC
New York, NY |
Oct 22, 2024 Q3 2024 |
710
shares
|
$2,094
0.0% of portfolio
|
Q2 2023
Added 100.0%
|
|
|
Nisa Investment Advisors, LLC
|
Oct 24, 2024 Q3 2024 |
610
shares
|
$1,799
0.0% of portfolio
|
Q4 2023
Reduced 8.96%
|
|
|
Baystate Wealth Management LLC
|
Jan 29, 2024 Q4 2023 |
500
shares
|
$1,475
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Allworth Financial LP
|
Oct 23, 2024 Q3 2024 |
351
shares
|
$1,035
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
New Edge Advisors, LLC
New Orleans, LA |
Nov 14, 2024 Q3 2024 |
300
shares
|
$885
0.0% of portfolio
|
Q3 2024
Reduced 50.0%
|
|
|
Parkside Financial Bank & Trust
|
Nov 07, 2024 Q3 2024 |
200
shares
|
$590
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Trustcore Financial Services, LLC
|
Feb 13, 2023 Q4 2022 |
161
shares
|
$474
0.0% of portfolio
|
Q4 2021
Reduced 66.53%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
135
shares
|
$398
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Continuum Advisory, LLC
Eagle, ID |
Nov 15, 2024 Q3 2024 |
93
shares
|
$274
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
75
shares
|
$221
0.0% of portfolio
|
Q2 2021
Added 400.0%
|
|
|
Morton Brown Family Wealth, LLC
|
Oct 24, 2024 Q3 2024 |
75
shares
|
$221
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Dcvc Bio Gp, LLC
Palo Alto, CA |
Nov 14, 2022 Q3 2022 |
0
shares
|
$0
100.0% of portfolio
|
Q3 2022
Closed
|